Try our beta test site
1 study found for:    483-013
Show Display Options
Rank Status Study
1 Recruiting Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
Condition: Nocturia
Interventions: Drug: Fedovapagon 2 mg;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.